Abnormalities of glycosphingolipids in mucopolysaccharidosis type III B.

Abnormalities of glycosphingolipids in mucopolysaccharidosis type III B.

Glycosphingolipids from brain, liver, and spleen of a patient with mucopolysaccharidosis type III B were quantitatively analyzed. Neutral glycosphingolipids containing glucosylceramide, lactosylceramide, globotriaosylceramide, globotetraosylceramide, and gangliotriaosylceramide were increased in the...

Full description

Bibliographic Details
Main Authors:	A Hara, N Kitazawa, T Taketomi
Format:	Article
Language:	English
Published:	Elsevier 1984-02-01
Series:	Journal of Lipid Research
Online Access:	http://www.sciencedirect.com/science/article/pii/S0022227520378378

Similar Items

Hip pathologies in mucopolysaccharidosis type III
by: Sandra Rafaela Breyer, et al.
Published: (2021-03-01)

Assessment of sleep in children with mucopolysaccharidosis type III.
by: Louise Victoria Mahon, et al.
Published: (2014-01-01)

Airway Abnormalities in Adult Mucopolysaccharidosis and Development of Salford Mucopolysaccharidosis Airway Score
by: Chaitanya Gadepalli, et al.
Published: (2021-07-01)

Abnormalities of glycosphingolipid, sulfatide, and ceramide in the polycystic (cpk/cpk) mouse.
by: G D Deshmukh, et al.
Published: (1994-09-01)

Evaluation of Cardiac Findings in Mucopolysaccharidosis Type III Patients
by: Berrak Bilginer Gürbüz, et al.
Published: (2021-06-01)

Abnormal fatty acid composition of erythrocyte glycosphingolipids in congenital dyserythropoietic anemia type II.
by: J F Bouhours, et al.
Published: (1985-04-01)

Cognitive development in patients with Mucopolysaccharidosis type III (Sanfilippo syndrome)
by: Colland Vivian, et al.
Published: (2011-06-01)

Recommendations on clinical trial design for treatment of Mucopolysaccharidosis Type III
by: Arunabha Ghosh, et al.
Published: (2017-06-01)

Growth charts for patients with Sanfilippo syndrome (Mucopolysaccharidosis type III)
by: Nicole M. Muschol, et al.
Published: (2019-05-01)

MUCOPOLYSACCHARIDOSIS TYPE II
by: N.D. Vashakmadze, et al.
Published: (2011-06-01)

MUCOPOLYSACCHARIDOSIS TYPE II
by: N.D. Vashakmadze, et al.
Published: (2011-06-01)

Protein misfolding as an underlying molecular defect in mucopolysaccharidosis III type C.
by: Matthew Feldhammer, et al.
Published: (2009-10-01)

Mucopolysaccharidosis Type I
by: Francyne Kubaski, et al.
Published: (2020-03-01)

Lipidomics of Glycosphingolipids
by: Hany Farwanah, et al.
Published: (2012-02-01)

Skeletal Abnormalities and VDR1 Gene Polymorphisms in Mucopolysaccharidosis Patients
by: Alkhzouz C, et al.
Published: (2021-03-01)

Unveiling metabolic remodeling in mucopolysaccharidosis type III through integrative metabolomics and pathway analysis
by: Abdellah Tebani, et al.
Published: (2018-09-01)

Antigenic properties of glycosphingolipids
by: Herbert, S. J.
Published: (1988)

CARDIOVASCULAR PATHOLOGY IN CHILDREN WITH TYPE I MUCOPOLYSACCHARIDOSIS
by: N. D. Vashakmadze, et al.
Published: (2014-07-01)

Identification of age-dependent motor and neuropsychological behavioural abnormalities in a mouse model of Mucopolysaccharidosis Type II.
by: Hélène F E Gleitz, et al.
Published: (2017-01-01)

Cardiac characteristics and natural progression in Taiwanese patients with mucopolysaccharidosis III
by: Hsiang-Yu Lin, et al.
Published: (2019-06-01)

Mucopolysaccharidosis Type II in the Practice of the Physician
by: I.Y. Vatanskaya, et al.
Published: (2016-09-01)

Atypical presentation of mucopolysaccharidosis type IVA
by: Eric T. Rush
Published: (2016-09-01)

Molecular genetics of mucopolysaccharidosis Type I
by: Chan yi-wen, et al.
Published: (1998)

Mucopolysaccharidosis
by: Nicole Ruas Guarany PhD, et al.
Published: (2015-11-01)

Glycosphingolipids and neuroinflammation in Parkinson’s disease
by: Karim Belarbi, et al.
Published: (2020-10-01)

Glycosphingolipids from cultured astroblasts
by: J Robert, et al.
Published: (1977-07-01)

Glycosphingolipids in the spleen of developing rats
by: TERRENCE T. KUSKE, et al.
Published: (1971-03-01)

Acid hydrolysis of neutral glycosphingolipids
by: Nardan, Denise
Published: (2008)

Features and behavior of valvular abnormalities in adolescent and adult patients in mucopolysaccharidosis: an echocardiographic study
by: Domenico Galzerano, et al.
Published: (2021-08-01)

Orthopedic Pathology in Children with Mucopolysaccharidosis Type I
by: Nato D. Vashakmadze, et al.
Published: (2016-12-01)

Mucopolysaccharidosis Type 3B in an Adult with Pancytopenia: A Rare Case Report
by: Alparslan Merdin, et al.
Published: (2014-09-01)

Skeletal system involvement in patients with mucopolysaccharidosis type I
by: N. D. Vashakmadze, et al.
Published: (2016-09-01)

The Role of Glycosphingolipids in Immune Cell Functions
by: Tao Zhang, et al.
Published: (2019-01-01)

Simultaneous quantification of lyso-neutral glycosphingolipids and neutral glycosphingolipids by N-acetylation with [3H]acetic anhydride
by: Jacques Bodennec, et al.
Published: (2003-07-01)

Glycosylphosphatidylinositol anchors regulate glycosphingolipid levels[S]
by: Ursula Loizides-Mangold, et al.
Published: (2012-08-01)

Study on the Synthesis of Glycosphingolipids with Neuritogenic Bioactivity: Synthesi of Glycosphingolipids DSG-1 Analogue DSG-1a
by: Jheng-Hua Shih, et al.
Published: (2011)

Heart damage in mucopolysaccharidosis
by: M. I. Dovgan, et al.
Published: (2016-03-01)

Apoptotic modification of glycosphingolipids of human granulocytes
by: A. M. Tomin, et al.
Published: (2012-09-01)

Biomarkers in patients with mucopolysaccharidosis type II and IV
by: Honoka Fujitsuka, et al.
Published: (2019-06-01)

A Case Report of Mucopolysaccharidosis Type VI
by: SJ Hosseini, et al.
Published: (2018-12-01)